Search Results
Results found for "GPCR autoantibodies"
Posts (682)
- Antibodies That Don’t Block, They Activate: A New Angle on Autoimmunity and GPCRs
Tom Sakmar points to a largely overlooked mechanism in disease: autoantibodies that don’t block receptors Screen patient samples for GPCR autoantibodies Identify which receptor is being bound Determine if the Classic ELISAs Traditional autoantibody testing relies on single-target ELISAs . for detection, but for functional screening : add ligands, track modulation, and even identify biased autoantibodies This is the future of GPCR immunology . ________________ Keyword Cloud : GPCR autoantibodies , GPCR immunology
- Dr. GPCR Updates
GPCR – Precision Tools for GPCR Assays Dr. GPCR and Celtarys Research have teamed up. features a discussion about a scalable GPCR-RAMP assay. Their global resource is now helping labs decode GPCR biology at scale. It’s exciting to see how the GPCR field is evolving. GPCR Team
- Accelerating GPCR Drug Discovery
But your GPCR program still isn't moving at the pace it should. The GPCR Data Dilemma: The Lego Bucket Problem I've seen promising GPCR programs generate massive volumes GPCR As the co-founder of Dr. GPCR, we've built a global hub connecting over 1,300 GPCR scientists dedicated to this field. Ready to Move Your GPCR Program Forward?
Other Pages (466)
- Autoantibodies that activate GPCRs? Wild—but real. Tom Sakmar & Ilana Kotliar break down the link between GPCR autoantibodies, long COVID, and disease signaling in Ep.167 of the Dr.GPCR Podcast This episode is a must if you're thinking diagnostics. 📲 Tap to listen: Ep 167 with Drs. Tom Sakmar & Ilana Kotliar #GPCRautoantibodies #GPCRdrugdiscovery #DrGPCR #Immunology | Dr. GPCR Ecosystem
Home → Flash News → Autoantibodies that activate GPCRs? Wild—but real. Tom Sakmar & Ilana Kotliar break down the link between GPCR autoantibodies, long COVID, and disease signaling GPCR Podcast Autoantibodies that activate GPCRs? Wild—but real. Tom Sakmar & Ilana Kotliar break down the link between GPCR autoantibodies, long COVID, and disease signaling
- Hacking GPCRs: Tools, Tech & Drug Discovery with Tom Sakmar & Ilana Kotliar | Dr. GPCR Ecosystem
Ilana Kotliar built a multiplexed platform to map GPCR-RAMP interactions and uncover autoantibody-driven A Diagnostic Future “Autoantibodies targeting GPCRs might drive disease.” – Tom Sakmar One especially The team envisions using these tools to detect GPCR autoantibodies , which are implicated in conditions Unlike blocking antibodies, some autoantibodies activate GPCRs , potentially driving pathophysiology GPCR ecosystem , GPCR data platform , GPCR autoantibodies , Addgene GPCR library , GPCR training program
- Dr. GPCR Community Presentation | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Full Agenda Adhesion GPCR workshop 2024 CINVESTAV, Mexico City, Mexico October 23-25 Download PDF Program GPCR Community Presentation Breaking Barriers: My Journey from Mexico to the Heart of the Dr. GPCR Ecosystem and beyond About Monserrat Avila Zozaya "My doctoral research was focused on investigating My research focuses on understanding the molecular mechanisms of adhesion GPCRs (aGPCRs) in lymphatic GPCR < Previous Session Next Session >
Events (6)
- May 9, 2024 | 2:00 PM
- Development of GPCR Ligands as Therapeutic DrugsTickets: $0.00March 20, 2025 | 2:00 PM
- September 24, 2025 | 10:00 PM105 Huntington Ave, Boston, MA 02199, USA







